In last trading session, Health Catalyst Inc (NASDAQ:HCAT) saw 0.31 million shares changing hands with its beta currently measuring 1.35. Company’s recent per share price level of $7.79 trading at -$0.07 or -0.89% at ring of the bell on the day assigns it a market valuation of $448.31M. That closing price of HCAT’s stock is at a discount of -103.72% from its 52-week high price of $15.87 and is indicating a premium of 15.28% from its 52-week low price of $6.60. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 448.94K if we extend that period to 3-months.
For Health Catalyst Inc (HCAT), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 1.88. Splitting up the data highlights that, out of 16 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 7 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $HCA Healthcare, Inc. in the current quarter.
Health Catalyst Inc (NASDAQ:HCAT) trade information
Upright in the red during last session for losing -0.89%, in the last five days HCAT remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $7.79 price level, adding 8.57% to its value on the day. Health Catalyst Inc’s shares saw a change of -26.72% in year-to-date performance and have moved 16.10% in past 5-day. Health Catalyst Inc (NASDAQ:HCAT) showed a performance of -4.42% in past 30-days. Number of shares sold short was 1.51 million shares which calculate 3.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $11.69 to the stock, which implies a rise of 33.36% to its current value. Analysts have been projecting $8.00 as a low price target for the stock while placing it at a high target of $16.00. It follows that stock’s current price would drop -105.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2.7% for stock’s current value.
Health Catalyst Inc (HCAT) estimates and forecasts
Statistics highlight that Health Catalyst Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -27.20% of value to its shares in past 6 months, showing an annual growth rate of 142.31% while that of industry is 16.10. Apart from that, the company came raising its revenue forecast for fiscal year 2023.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -10.28% during past 5 years.
Health Catalyst Inc is more likely to be releasing its next quarterly report on November 02 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Health Catalyst Inc (NASDAQ:HCAT)’s Major holders
Insiders are in possession of 2.48% of company’s total shares while institution are holding 90.05 percent of that, with stock having share float percentage of 92.34%. Investors also watch the number of corporate investors in a company very closely, which is 90.05% institutions for Health Catalyst Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at HCAT for having 6.36 million shares of worth $79.54 million. And as of Jun 29, 2023, it was holding 11.17% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 4.76 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.35% of outstanding shares, having a total worth of $59.49 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.63 million shares of worth $20.33 million or 2.85% of the total outstanding shares. The later fund manager was in possession of 1.38 million shares on Jun 29, 2023, making its stake of worth around $17.27 million in the company or a holder of 2.43% of company’s stock.